Overview of a promising new study of venetoclax in patients with CLL
FCR or FR – which regimen is better for treating CLL?
The road to individualized treatment for CLL
How far are we from a cure for CLL?
Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL